ArticleDermato-endocrinology2012

Association of ustekinumab and briakinumab with major adverse cardiovascular events: An appraisal of meta-analyses and industry sponsored pooled analyses to date.

Thrasivoulos Tzellos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.